Gout Trials in Hickory, United States
Conditions / Gout / Hickory, United States
Gout is a medical condition with active clinical research programs worldwide.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01650246 | Open-Label Lesinurad Monotherapy Extension Study in Gout | COMPLETED | PHASE3 |
| NCT01808131 | Lesinurad and Allopurinol Combination Extension Study in Gout | COMPLETED | PHASE3 |
| NCT01508702 | Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors | COMPLETED | PHASE3 |
| NCT01391325 | Allopurinol Outcome Study | COMPLETED | PHASE4 |
| NCT06229145 | A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout | ACTIVE_NOT_RECRUITING | PHASE4 |
| NCT02139046 | Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout | COMPLETED | PHASE3 |
| NCT01493531 | Combining Lesinurad With Allopurinol in Inadequate Responders | COMPLETED | PHASE3 |
| NCT02063997 | Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients | COMPLETED | PHASE2 |
| NCT00856206 | Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE) | COMPLETED | PHASE3 |
| NCT01927198 | RDEA3170 Monotherapy in Subjects With Gout | COMPLETED | PHASE2 |